Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | PD 0360324 |
| Trade Name | |
| Synonyms | PD-0360324|PD0360324 |
| Drug Descriptions |
PD 0360324 is a monoclonal antibody that targets CSF1 (M-CSF) and interferes with CSF1 receptor binding, which may result in increased anti-tumor immune response (PMID: 26376111). |
| DrugClasses | CSF1 Antibody 2 |
| CAS Registry Number | 1822383-05-0 |
| NCIT ID | C131301 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Avelumab + PD 0360324 | Avelumab PD 0360324 | 0 | 1 |
| Cyclophosphamide + PD 0360324 | Cyclophosphamide PD 0360324 | 0 | 1 |
| PD 0360324 | PD 0360324 | 0 | 0 |